jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Anaerobic Culture and Susceptibility (Manual method)

Bacterial/ Viral
image

Report in 144Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Culture and antibiotic sensitivity testing for anaerobic bacteria using conventional techniques.

1,5762,252

30% OFF

Anaerobic Culture and Susceptibility (Manual Method) - Comprehensive Guide

  • Why is it done?
    • Identifies and isolates anaerobic bacteria from clinical specimens that thrive in oxygen-free environments
    • Determines antibiotic susceptibility patterns of anaerobic pathogens using manual laboratory techniques
    • Diagnoses infections involving anaerobic bacteria in intra-abdominal, pelvic, respiratory, and soft tissue infections
    • Guides targeted antibiotic therapy by identifying which antimicrobial agents are most effective against isolated organisms
    • Typically performed when anaerobic infection is clinically suspected based on specimen source, presentation, or Gram stain findings
    • Indicated for samples from normally sterile body sites that may contain pathogenic anaerobes
  • Normal Range
    • Normal Result: No growth of anaerobic bacteria after 48-72 hours of culture
    • Interpretation: Negative culture indicates absence of significant anaerobic infection at the site sampled
    • Positive Result: Growth of anaerobic bacteria isolated and identified
    • Susceptibility Results: Reported as Susceptible (S), Intermediate (I), or Resistant (R) for each antimicrobial agent tested using CLSI standards
    • Units: Minimum Inhibitory Concentration (MIC) in µg/mL or qualitative categories (S/I/R)
  • Interpretation
    • No Growth: Indicates either the specimen does not contain viable anaerobic pathogens or the anaerobes were eliminated by prior antibiotic therapy. May represent normal flora or contamination.
    • Isolated Organism Identification: Report specifies anaerobic species (e.g., Bacteroides fragilis, Clostridium difficile, Peptostreptococcus, Prevotella, Fusobacterium) which indicates true anaerobic infection
    • Susceptible (S): Antibiotic is likely effective at standard clinical dosages; recommended for therapy
    • Intermediate (I): Antibiotic may be effective depending on concentration achievable at infection site; used when clinical circumstances warrant
    • Resistant (R): Antibiotic is ineffective; organism is unlikely to respond to therapy; avoid this agent
    • Mixed Flora Results: Multiple anaerobic species may be isolated; each reported with individual identification and susceptibilities
    • Factors Affecting Results: Specimen collection method, transport time, prior antibiotic exposure, specimen quality, and proper anaerobic handling all impact culture results
  • Associated Organs
    • Primary Organ Systems Involved:
    • Gastrointestinal tract - intra-abdominal infections, appendicitis, diverticulitis, peritonitis
    • Reproductive system - pelvic inflammatory disease, tubo-ovarian abscesses, endometritis, bacterial vaginosis complications
    • Biliary system - cholecystitis, cholangitis
    • Respiratory tract - lung abscesses, empyema, aspiration pneumonia
    • Soft tissues and skin - diabetic foot ulcers, necrotizing fasciitis, surgical site infections
    • Central nervous system - brain abscesses, subdural empyema
    • Bloodstream - bacteremia, sepsis, endocarditis
    • Associated Medical Conditions:
    • Anaerobic infections from Bacteroides fragilis, Clostridium species, Prevotella, Peptostreptococcus, and Fusobacterium
    • Polymicrobial infections combining aerobic and anaerobic organisms
    • Healthcare-associated infections with resistant anaerobic strains
    • Potential Complications:
    • Sepsis and septic shock if anaerobic infection progresses untreated
    • Abscess formation and spread of infection to adjacent tissues
    • Organ dysfunction or failure related to anatomical involvement
    • Treatment delays if results are not interpreted correctly or culture contamination occurs
  • Follow-up Tests
    • Additional Testing Based on Results:
    • Repeat culture if initial results show contamination or if clinical response is inadequate
    • Aerobic culture and susceptibility from same specimen source to identify concurrent aerobic pathogens
    • Blood cultures if bacteremia or sepsis is suspected
    • Complete blood count (CBC) to assess inflammatory response and white blood cell elevation
    • Comprehensive metabolic panel to evaluate organ function and metabolic effects of infection
    • Lactate level to assess severity of infection and tissue hypoxia
    • Procalcitonin or C-reactive protein to monitor inflammatory markers
    • Imaging studies (CT, ultrasound, MRI) if abscess localization is needed for drainage procedures
    • Monitoring and Surveillance:
    • Clinical response monitoring within 24-48 hours of therapy initiation
    • Repeat cultures if infection persists despite appropriate therapy (every 48-72 hours as clinically indicated)
    • Clinical reassessment for adequate source control (drainage of abscesses)
    • Serial inflammatory markers to confirm clinical improvement
    • Complementary Tests:
    • Gram stain of the original specimen for morphological characteristics aiding identification
    • PCR or molecular identification for rapid anaerobic species detection
    • Toxin assays if Clostridium difficile is isolated
  • Fasting Required?
    • Fasting: No
    • Fasting is not required for anaerobic culture collection as specimens are obtained directly from the infection site
    • Specimen Collection Instructions:
    • Collect specimens in appropriate anaerobic transport systems (anaerobic swabs or syringes with oxygen-free environment)
    • Avoid exposure to air; maintain anaerobic conditions during collection and transport
    • Transport specimens promptly to laboratory (preferably within 15-30 minutes)
    • Medications to Avoid:
    • If possible, postpone antibiotic therapy until after specimen collection to improve culture sensitivity
    • If already on antibiotics, notify laboratory as this may affect culture results
    • Additional Preparation:
    • Disinfect skin with appropriate agents before percutaneous specimen collection to reduce surface contamination
    • Use sterile technique to prevent contamination with skin flora or environmental organisms
    • Do not use formalin or other preservatives as these kill anaerobic organisms
    • Collect adequate volume of specimen (minimum 1 mL fluid or tissue) for optimal culture sensitivity

How our test process works!

customers
customers